Search Within

Santosha Adipudi Vardhana

Formats
  1. Meeting Abstract (53)
  2. Journal Article (38)
  3. Editorial (9)
  4. Research Letter (6)
  5. Review (5)
  6. Conference Paper (2)
Groups
  1. Center for Hematologic Malignancies (113)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (113)
  3. Department of Medicine (113)
  4. GSK Faculty (113)
  5. Hematologic Malignancies, Division of (113)
  6. Human Oncology and Pathogenesis Program (113)

More Groups

People
  1. Alison Moskowitz (46)
  2. Anita Kumar (43)
  3. Steven Horwitz (43)
  4. Andrew Zelenetz (41)
  5. Ariela Noy (39)
  6. Lorenzo Falchi (38)

More People

Years
  1. 2025 (5)
  2. 2024 (25)
  3. 2023 (29)
  4. 2022 (18)
  5. 2021 (13)
  6. 2020 (10)

More Years

Publications
  1. Blood (39)
  2. Journal of Clinical Oncology (10)
  3. Hematological Oncology (5)
  4. Annals of Surgical Oncology (4)
  5. Blood Advances (4)
  6. Annals of Surgery (3)

More Publications

Publishers
  1. American Society of Hematology (43)
  2. American Society of Clinical Oncology (11)
  3. Nature Publishing Group (9)
  4. Cell Press (8)
  5. American Association for Cancer Research (6)
  6. Elsevier Inc. (6)

More Publishers

Results (113)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: Insights from a retrospective analysis
    Journal Article

    Luttwak, E.; Robin, E. T.; Drill, E.; Boardman, A.; Caron, P.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Tackling the next decade of cancer research
    Editorial

    Ali, R.; Jenkins, B.; Karthaus, W.; Lipkova, J.; Misale, S.; Puschhof, J.; Smith, M.; Vardhana, S.; Zhou, X.
    Trends in Cancer (2025)

    Fulltext@MSK | Save
  • Case report: Decentralized trial of tolerability-adapted exercise therapy after severe COVID-19
    Journal Article

    Scott, J. M.; Qiu, Z.; Rahman, J.; Moskowitz, C. S.; Michalski, M. G.; Lehman, S.; Lee, C. P.; Harrison, J.; Yu, A. F.; Marouf, A.; more...
    Frontiers in Immunology (2025)

    Fulltext@MSK | Save
  • Host tissue factors predict immune surveillance and therapeutic outcomes in gastric cancer
    Journal Article

    Abate, M.; Stroobant, E. E.; Fei, T.; Lin, Y. H.; Shimada, S.; Drebin, H.; Chen, E.; Tang, L. H.; Shah, S. P.; Wolchok, J. D.; more...
    Cancer Immunology Research (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Two decade single institution experience highlights rare survivors with relapsed or refractory Burkitt lymphoma
    Meeting Abstract

    Molla, R.; Berman, E.; Caron, P.; Donnelly, G.; Falchi, L.; Hamlin, P. A.; Horwitz, S.; Intlekofer, A. M.; Johnson, W. T.; Jurcic, J. G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Angioimmunoblastic versus non-angioimmunoblastic nodal T-follicular helper cell lymphomas: Single center retrospective analysis on 208 cases
    Meeting Abstract

    Sordi, B.; Eren, O. C.; Ganesan, N.; Iyengar, V.; Stuver, R.; Johnson, W. T.; Moskowitz, A.; Ghione, P.; Galasso, N.; Casper, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A prospective geriatric assessment (GA) study predicting toxicities in older adults (OA) with non-Hodgkin Lymphoma (NHL): Timed up and go test (TUG) time emerges as a functional vital sign
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Truong, R.; Qiu, A.; Amador, W. R.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pembrolizumab and involved site radiation therapy alone as an alternative to transplant in patients with localized failure following chemotherapy for Hodgkin Lymphoma: A prospective multicenter phase II study
    Meeting Abstract

    Dreyfuss, A.; Ganesan, N.; Alencar, A. J.; Boardman, A. P.; Caron, P.; Chang, T.; Davey, T.; David, K. A.; Dogan, A.; Epstein-Peterson, Z. D.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Improved outcomes for primary refractory classical Hodgkin Lymphoma: A retrospective analysis
    Meeting Abstract

    Santarosa, A. M.; Ganesan, N.; Chang, T.; Hannigan, K.; Casper, E.; Shah, G. L.; Boardman, A. P.; Caron, P.; David, K. A.; Dogan, A.; more...
    Blood (2024)

    Fulltext@MSK | Save